1.
Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
by Thijssen, Elisabeth H
Nature medicine, 2020-03-01, Vol.26 (3), p.387-397
2.
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
by Kroth, Heiko
European journal of nuclear medicine and molecular imaging, 2019-07-01, Vol.46 (10), p.2178-2189
3.
Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy
by Nielsen, Berit Dalsgaard
European journal of nuclear medicine and molecular imaging, 2018-04-18, Vol.45 (7), p.1119-1128
4.
Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma : a systematic review and meta-analysis
by Burggraaff, Coreline N
European journal of nuclear medicine and molecular imaging, 2019-01, Vol.46 (1), p.65-79
5.
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations
by Mayerhoefer, Marius E
European journal of nuclear medicine and molecular imaging, 2019-08-13, Vol.47 (1), p.51-60
6.
Neurogenetic contributions to amyloid beta and tau spreading in the human cortex
by Sepulcre, Jorge
Nature medicine, 2018-12, Vol.24 (12), p.1910-1918
7.
Feasibility of state of the art PET/CT systems performance harmonisation
by Kaalep, Anes
European journal of nuclear medicine and molecular imaging, 2018-07, Vol.45 (8), p.1344-1361
8.
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)
by Nanni, Cristina
European journal of nuclear medicine and molecular imaging, 2017-12-21, Vol.45 (5), p.712-719
9.
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by t...
by Slart, Riemer H. J. A
European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (7), p.1250-1269
10.
EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
by Giovanella, Luca
European journal of nuclear medicine and molecular imaging, 2019-09-04, Vol.47 (1), p.61-77
11.
Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
by Camus, V
European journal of nuclear medicine and molecular imaging, 2012-01-18, Vol.39 (4), p.621-631
12.
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance
by Helsen, Nils
European journal of nuclear medicine and molecular imaging, 2018-02-24, Vol.45 (6), p.1063-1071
13.
External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy
by Lucia, François
European journal of nuclear medicine and molecular imaging, 2018-12-07, Vol.46 (4), p.864-877
14.
PET image denoising using unsupervised deep learning
by Cui, Jianan
European journal of nuclear medicine and molecular imaging, 2019-08-29, Vol.46 (13), p.2780-2789
15.
In response to: The validity of 18 F-GE180 as a TSPO imaging agent
by Albert, Nathalie L
European journal of nuclear medicine and molecular imaging, 2019-06, Vol.46 (6), p.1208
16.
Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma
by Rohde, Max
European journal of nuclear medicine and molecular imaging, 2017-11-10, Vol.45 (4), p.613-621
17.
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment
by Bosch, Karen D
European journal of nuclear medicine and molecular imaging, 2019-08-03, Vol.47 (4), p.759-767
18.
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
by Leuzy, Antoine
European journal of nuclear medicine and molecular imaging, 2019-01-04, Vol.46 (5), p.1152-1163
19.
Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
by McCluskey, Stuart P
European journal of nuclear medicine and molecular imaging, 2019-09-21, Vol.47 (2), p.451-489
20.
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
by Bouwman, Femke
European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (9), p.1526-1533
Filter electronic articles 3.234 Hits
Remove Filters
- Subjects
- Positron-Emission Tomography
- Humans (3.044)
- Science & Technology (2.199)
- more ...